Imagine a world where a simple mineral could hold the key to unlocking the mysteries of multiple sclerosis (MS). But here's where it gets controversial: could something as common as copper be the missing link tying together the complex web of MS risk factors? MS Australia’s groundbreaking $2.8 million research grant round aims to tackle this very question, addressing long-standing gaps in MS genetics and exploring innovative ways to slow disease progression, manage symptoms, and enhance quality of life.
Multiple sclerosis is an autoimmune disorder where the body’s immune system mistakenly attacks the brain and spinal cord, damaging myelin—the protective sheath surrounding nerve fibers. This damage can lead to a range of debilitating symptoms, from mobility issues and vision problems to cognitive challenges and chronic fatigue. And this is the part most people miss: by 2025, over 37,700 Australians will be living with MS, marking a staggering 77.4% increase since 2010. The economic toll? A whopping $3 billion in 2024 alone. With these numbers on the rise, the need for accelerated research has never been more urgent.
One of the standout projects in this initiative is led by Dr. Brittney Lins, a Postdoctoral Fellow at Curtin University and the Perron Institute. Dr. Lins is investigating whether disrupted copper levels in the brain could be the thread connecting major MS risk factors, such as Epstein-Barr virus infection, vitamin D deficiency, and gut health. Her research will delve into whether copper imbalance contributes to myelin damage, with the ultimate goal of uncovering new prevention and treatment strategies.
Here’s the bold part: copper, a trace nutrient found in our food, exists in tiny amounts in the body but plays a colossal role in energy utilization and antioxidant defenses. Dr. Lins hypothesizes, ‘If copper utilization is disrupted, myelin may become more susceptible to inflammation and autoimmune attacks. Copper could be the missing piece that links multiple MS risk factors together.’ This perspective challenges conventional thinking and opens the door to potentially revolutionary discoveries.
Dr. Rebekah Puls, Head of Research at the Perron Institute, emphasizes the significance of Dr. Lins’ work: ‘This exciting preclinical project leverages cutting-edge synchrotron microscopy, allowing us to image copper levels in the brain like never before. These advancements enable discoveries that were once unimaginable.’ If copper imbalance is indeed at the heart of MS susceptibility, it could reshape our approach to prevention and treatment.
Collaborating on this project are Associate Professor Mark Hackett from Curtin University, along with Professor Lindy Fitzgerald, Dr. Sarah Hellewell, and Dr. Chidozie Anyaegbu from the Curtin University and Perron Institute Neurotrauma Research group. Their combined expertise promises to drive this research forward with precision and innovation.
Over two decades, MS Australia has invested over $60 million in MS research, a testament to their unwavering commitment to finding solutions. CEO Rohan Greenland underscores the importance of sustained national investment: ‘Research is hope. It reminds those living with MS that progress is possible, and better treatments are within reach. This wouldn’t be achievable without the dedication of our Member Organisations, donors, and the broader MS community. Together, we’re accelerating discoveries that bring us closer to a world without MS.’
The research grants will officially launch on March 4th at Parliament House in Canberra during MS Australia’s Advancing MS Research in Australia event. Notable speakers, including Dr. Monique Ryan MP and Ms. Renee Coffey MP, will highlight the critical need for continued national support for MS research. But here’s the question we leave you with: Could copper really be the game-changer in MS research, or is it just one piece of a much larger puzzle? Share your thoughts in the comments—we’d love to hear your perspective!
